Switching Between Advanced Weight Management Treatments
Can I Switch From Wegovy to Mounjaro—Understanding Your Options
When considering whether you can switch from Wegovy to Mounjaro, it's essential to understand that these are two distinct prescription-only medicines with different mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. The decision to switch should always be made in consultation with your prescriber, who can assess your current treatment response, any side effects you may be experiencing, and your overall health profile.
At EverydayMeds, we maintain comprehensive stock levels of both treatments, ensuring that patients can access their prescribed medication without delays. Our clinical team understands the complexities involved when patients ask "can I switch from Wegovy to Mounjaro" and provides thorough assessments to support safe treatment transitions. Both medications are readily available through our GPhC-registered pharmacy (#9012878), eliminating the uncertainty that has historically affected weight management treatment access.
Pricing and Value for Both Treatment Options
Understanding the cost implications when you switch from Wegovy to Mounjaro helps inform your treatment decision. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenient dosing progressions, such as the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Mounjaro follows a different pricing structure due to its dual-receptor mechanism, and patients considering whether they can switch from Wegovy to Mounjaro often find the investment worthwhile for the enhanced treatment approach. Both medications represent significant advances in weight management technology, and our bundle options help ensure consistent supply throughout your treatment journey. The Consistency bundles provide two pens of the same dose, whilst our Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99.
Clinical Evidence Supporting Both Treatment Approaches
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 extension study showed sustained results of approximately clinically studied weight loss at two years, whilst the SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events.
When patients ask "can I switch from Wegovy to Mounjaro," they're often seeking to compare these evidence bases, though direct head-to-head trials haven't been conducted. Tirzepatide's dual-receptor approach may offer additional benefits for some patients, whilst others respond optimally to semaglutide's established GLP-1 mechanism. Both treatments require commitment to lifestyle modifications and represent long-term approaches to weight management rather than short-term solutions.
How Wegovy Works in Your Body
Wegovy's active ingredient, semaglutide, mimics a natural hormone called GLP-1 that your intestines release after eating. This hormone normally signals to your brain that you're full and satisfied, but in people struggling with weight management, these signals may be impaired or insufficient. By activating GLP-1 receptors throughout your body, Wegovy helps restore these natural fullness cues and reduces appetite between meals. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety after smaller portions. Additionally, Wegovy may help reduce food cravings by working directly on appetite centres in the brain, though individual responses can vary significantly.
Streamlined Ordering Process for Both Treatments
Whether you're asking "can I switch from Wegovy to Mounjaro" or starting treatment for the first time, our ordering process ensures safe, legal access to these prescription-only medicines. The journey begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any previous treatment experiences. Our qualified prescribers then review your assessment, typically within 3 working days (express 24-hour service available), to determine the most appropriate treatment and dosing schedule. Once approved, your medication ships via next-day delivery using specialist cold-chain packaging to maintain optimal temperature throughout transit. This temperature-controlled approach ensures that your investment in advanced weight management technology arrives in perfect condition and ready for immediate use.
Storage Requirements and Practical Considerations
Both Wegovy and Mounjaro require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel convenience with 6 weeks of room temperature stability (below 30°C) once removed from the fridge, compared to Mounjaro's 21-day limit. The Wegovy FlexTouch pen system provides intuitive dose administration with clear dose escalation markings, progressing from 0.25mg through to the 2.4mg maintenance dose over 17 weeks. Each pen contains four weekly doses, and the dose escalation schedule cannot be rushed or skipped, as this helps minimise potential gastrointestinal side effects. Patients must follow the prescribed escalation timeline whether continuing with Wegovy or considering a switch to Mounjaro, as both treatments require gradual dose increases. The once-weekly injection schedule fits easily into most lifestyles, and the pen's discrete design allows for convenient storage during travel or at work.
Making Informed Decisions About Treatment Switching
The question "can I switch from Wegovy to Mounjaro" typically arises when patients experience side effects, reach a weight loss plateau, or seek enhanced results from tirzepatide's dual-receptor approach. Switching between these advanced treatments requires careful medical supervision, particularly regarding timing, dose equivalencies, and monitoring for any overlapping effects. Some patients find that Mounjaro's GIP receptor activity provides additional benefits, whilst others respond optimally to Wegovy's established semaglutide mechanism throughout their entire treatment journey.
At EverydayMeds, our clinical team regularly supports patients through these treatment transitions, ensuring continuity of care and optimal outcomes. The decision isn't simply about availability—though having both treatments in stock eliminates supply-related pressure—but rather about finding the most effective approach for your individual physiology and lifestyle. Both medications represent the cutting edge of weight management science, and having access to both options through the same trusted pharmacy ensures seamless transitions when medically appropriate.
Complete Treatment Access Without Delays
Unlike the supply challenges that historically affected weight management medications, EverydayMeds maintains robust stock levels across all Wegovy doses and Mounjaro strengths, ensuring that your question "can I switch from Wegovy to Mounjaro" can be answered with action rather than waitlists. Our direct relationships with Novo Nordisk and other pharmaceutical manufacturers, combined with sophisticated inventory management, mean that treatment interruptions due to supply issues are eliminated. Whether you need starter doses, maintenance strengths, or are transitioning between treatments, your prescribed medication ships within 24 hours of approval. This reliability proves essential for weight management success, as treatment consistency directly impacts long-term outcomes. Ready to explore your treatment options with complete confidence in medication availability? Browse our comprehensive Wegovy collection at https://everydaymeds.co.uk/collections/wegovy, complete your clinical assessment, and experience the difference that reliable access makes to your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
